S. Manopwisedjaroen

发表

Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations

K. Ruxrungtham, A. Thitithanyanont, W. Phoolcharoen, 2021, Vaccines.

Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro

A. Thitithanyanont, W. Phoolcharoen, B. Shanmugaraj, 2020, Frontiers in Plant Science.

Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity

S. Malaivijitnond, C. Klungthong, Taweewun Hunsawong, 2022, Vaccine.

DNA Vaccine Administered by Cationic Lipoplexes or by In Vivo Electroporation Induces Comparable Antibody Responses against SARS-CoV-2 in Mice

K. Ruxrungtham, S. Sirivichayakul, G. Borchard, 2021, Vaccines.

Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients: a Prospective Cohort Study

A. Thakkinstian, K. Malathum, S. Hongeng, 2022, Microbiology spectrum.

Virus MIP-composites for SARS-CoV-2 detection in the aquatic environment

C. Sangma, Wannisa Sukjee, C. Thepparit, 2022, Materials Letters.

High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents

P. Tuchinda, S. Borwornpinyo, A. Thitithanyanont, 2020, Scientific Reports.

Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations

P. Auewarakul, C. Boonarkart, S. Borwornpinyo, 2021, BMC pharmacology & toxicology.

Rapid and Scalable Production of Functional Anti-Coronavirus Monoclonal Antibody CR3022 in Plants

A. Thitithanyanont, W. Phoolcharoen, B. Shanmugaraj, 2020 .

Receptor binding domain proteins of SARS‐CoV‐2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern

S. Malaivijitnond, K. Srisutthisamphan, A. Jongkaewwattana, 2022, Journal of medical virology.

Trogocytosis with monocytes associated with increased α2,3 sialic acid expression on B cells during H5N1 influenza virus infection

A. Thitithanyanont, Sheng-Fan Wang, S. Manopwisedjaroen, 2020, PloS one.

CoronaVac induces lower neutralising activity against variants of concern than natural infection

S. Sangrajrang, W. Chantratita, A. Thitithanyanont, 2021, The Lancet Infectious Diseases.

SARS-CoV-2 variants of concern exhibit reduced sensitivity to live-virus neutralization in sera from CoronaVac vaccinees and naturally infected COVID-19 patients

W. Chantratita, A. Thitithanyanont, S. Sungkanuparph, 2021, medRxiv.

Dynamics of Neutralizing Antibodies and Binding Antibodies to Domains of SARS-CoV-2 Spike Protein in COVID-19 Survivors.

P. Auewarakul, C. Boonarkart, D. Chaiwanichsiri, 2022, Viral immunology.

A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera

E. Saphire, S. Hongeng, Eduardo Olmedillas, 2022, Antiviral Research.

A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques

S. Malaivijitnond, K. Srisutthisamphan, A. Jongkaewwattana, 2022, Frontiers in Plant Science.

Anti-SARS-CoV-2 Activity of Extracellular Vesicle Inhibitors: Screening, Validation, and Combination with Remdesivir

S. Borwornpinyo, S. Chutipongtanate, S. Hongeng, 2021, Biomedicines.

Rapid and Efficient Cell-to-Cell Transmission of Avian Influenza H5N1 Virus in MDCK Cells Is Achieved by Trogocytosis

S. Borwornpinyo, A. Thitithanyanont, Sheng-Fan Wang, 2021, Pathogens.

Anti-SARS-CoV-2 Activity of Andrographis paniculata Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives

S. Borwornpinyo, A. Thitithanyanont, S. Pitiporn, 2020, bioRxiv.

Favipiravir and Ivermectin Showed in Vitro Synergistic Antiviral Activity against SARS-CoV-2

P. Auewarakul, C. Boonarkart, S. Borwornpinyo, 2021 .

Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates

K. Ruxrungtham, S. Malaivijitnond, W. Wijagkanalan, 2021, Frontiers in Plant Science.

Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2

A. Thitithanyanont, S. Chutipongtanate, S. Sungkanuparph, 2021, bioRxiv.

Colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) as a visual diagnostic platform for the detection of the emerging coronavirus SARS-CoV-2.

T. Srikhirin, C. Samphaongern, A. Thitithanyanont, 2020, The Analyst.

Broad neutralization of SARS-CoV-2 variants by circular mRNA producing VFLIP-X spike in mice

E. Saphire, S. Hongeng, S. Manopwisedjaroen, 2022, bioRxiv.

SARS‐CoV‐2 neutralizing antibodies decline over one year and patients with severe COVID‐19 pneumonia display a unique cytokine profile

A. Thitithanyanont, S. Sungkanuparph, S. Hongeng, 2021, International Journal of Infectious Diseases.

Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana

A. Thitithanyanont, Duncan R. Smith, W. Phoolcharoen, 2020, Scientific Reports.

Target Enrichment Metagenomics Reveals Human Pegivirus-1 in Pediatric Hematopoietic Stem Cell Transplantation Recipients

W. Chantratita, S. Pakakasama, S. Hongeng, 2022, Viruses.

Translating a Thin-Film Rehydration Method to Microfluidics for the Preparation of a SARS-CoV-2 DNA Vaccine: When Manufacturing Method Matters

K. Ruxrungtham, A. Neels, G. Borchard, 2022, Pharmaceutics.

Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2

S. Borwornpinyo, A. Thitithanyanont, Duncan R. Smith, 2021, Frontiers in Plant Science.

Immunogenicity and efficacy of recombinant subunit SARS-CoV-2 vaccine candidate in the Syrian hamster model

W. Phoolcharoen, B. Shanmugaraj, S. Manopwisedjaroen, 2022, Biotechnology Reports.

Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice

D. Weissman, K. Ruxrungtham, J. Heyes, 2023, Nature communications.

Systematic Exploration of SARS-CoV-2 Adaptation to Vero E6, Vero E6/TMPRSS2, and Calu-3 Cells

J. Yuvaniyama, P. B. Purwono, S. Manopwisedjaroen, 2023, Genome biology and evolution.

Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant

S. Malaivijitnond, S. Pichyangkul, K. Srisutthisamphan, 2023, Vaccine.

Favipiravir and ivermectin show in vitro synergistic antiviral activity against SARS-CoV-2

P. Auewarakul, C. Boonarkart, S. Borwornpinyo, 2023, Acta Virologica.

Unveiling the Antiviral Properties of Panduratin A through SARS-CoV-2 Infection Modeling in Cardiomyocytes

S. Borwornpinyo, S. Hongeng, S. Manopwisedjaroen, 2024, International journal of molecular sciences.

In Vivo Evaluation of Andrographis paniculata and Boesenbergia rotunda Extract Activity Against SARS-CoV-2 Delta Variant in Golden Syrian Hamsters: Potential Herbal Alternative for COVID-19 Treatment

P. Vivithanaporn, S. Hongeng, Nitipol Srimongkolpithak, 2024, Journal of Traditional and Complementary Medicine.

Phase II prefusion non-stabilised Covid-19 mRNA vaccine randomised study

K. Ruxrungtham, T. Puthanakit, K. Srisutthisamphan, 2024, Scientific reports.